Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-25-034160

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Shahbazi Hamed Director 2025-06-24 Grant or award · Stock Option (right to buy) +20,000 20,000 D: show line 1 in the form
Loading xslF345X05/wk-form4_1751553733.xml…